| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.13 | - | - |
| Q2'26 | $1.08 | $1.27 | +17.3% |
| Q1'26 | $1.16 | $1.30 | +12.1% |
| Q4'25 | $1.14 | $1.13 | -0.7% |
| Q3'25 | $1.10 | $1.10 | -0.3% |
| Q2'25 | $1.02 | $1.05 | +2.5% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.9B | - | - |
| Q2'26 | $3.8B | $3.8B | -0.7% |
| Q1'26 | $3.8B | $3.7B | -2.4% |
| Q4'25 | $3.7B | $3.7B | +0.5% |
| Q3'25 | - | $3.2B | - |
| Q2'25 | - | $3.1B | - |
Market Data
WRB is currently trading at $68.60, giving W. R. Berkley Corporation a market cap of 25.89B and a P/E ratio of 13.4. Today's range spans $68.46–$69.75, with shares opening at $69.64 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 41/100 (HOLD) with a news sentiment reading of 50/100.
Over the past year WRB has traded between $62.87 and $78.96 - the current price is +9.1% off the 52-week low and -13.1% from the high. 29 analysts cover the stock with a Hold consensus and a mean 12-month target of $69.53 (range $51.00–$83.00), implying upside of +1.4%.
W. R. Berkley Corporation (WRB) is a large-cap in Financial Services with 25.89B in market cap, currently sitting on a HOLD signal at 41/100. Price: $68.60 (in the lower half of its 52-week range). Sentiment: neutral at 50/100. The current P/E ratio stands at 13.4. The 52-week range of $62.87–$78.96 is the structural anchor, and the current neutral phase is the market's way of asking for more information before committing to a direction.
The 52-week range of $62.87–$78.96 for WRB provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to, and at $68.60 (in the lower half of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 41/100 and neutral news backdrop (50/100) don't break the tie yet, but they narrow the probability distribution toward the upside.
W. R. Berkley’s 2025 revenue climbed to $3.715 B, marking a 19% year‑over‑year rise, while EPS consistently beat estimates in four of the last five quarters. The company’s 50+ specialized units provide a diversified portfolio across the U.S., U.K., and continental markets, supporting sustained premium growth. Recent leadership reshuffles, including a new reinsurance chief, signal a strategic push to streamline operations and capture synergies. These moves align with a broader industry trend toward consolidation, as larger insurers absorb niche carriers to expand geographic reach. The result is a more resilient underwriting base poised for continued expansion.
The P&C insurance landscape is experiencing accelerated consolidation, with larger carriers acquiring specialty units to broaden geographic reach.
WRB’s 50+ specialized units position it as a prime acquisition target for insurers seeking niche market exposure.
Recent leadership reshuffles signal strategic intent to streamline operations and unlock synergies in a competitive environment.
Quarterly EPS beats and a 11.3% annualized net premium growth demonstrate disciplined underwriting and loss‑ratio control.
The company’s float management has historically delivered investment income that offsets claim volatility, sustaining profitability.
Consistent revenue expansion from $3.015 B in Q4 2024 to $3.706 B in Q1 2026 underscores disciplined risk selection.
A $111.5 M share repurchase program coupled with a $13.9 B market cap reflects a strong capital allocation framework.
The company’s dividend payout remains modest, preserving cash for strategic acquisitions or underwriting growth.
With a forward PE of 13.9, WRB trades below the peer average of 17.8, offering a discount to valuation peers.
The Reinsurance & Monoline Excess segment provides treaty and facultative coverage, diversifying risk exposure across global markets.
Recent appointment of Daniel Westcott to a senior reinsurance role signals a focus on optimizing reinsurance placement and pricing.
Strategic reinsurance partnerships enhance capital efficiency and protect underwriting results from catastrophic events.
WRB competes with peers such as AIG and AFL, yet maintains a lower PE and a more concentrated specialty portfolio.
The company’s 52‑week low at $62.87 places it 12.8% above the low, indicating upside potential relative to recent lows.
Its diversified segments mitigate concentration risk, allowing resilience in volatile claim environments.
At a forward PE of 13.9, WRB trades at a discount to the peer average of 17.8, suggesting undervaluation relative to peers.
Analyst consensus of $69.29 implies a 3.6% upside from the current price of $71.6, but the high target of $83 signals potential upside.
The 52‑week high of $78.96 and low of $62.87 provide a 16.1% range, with the stock near the lower end of its cycle.
WRB trades at $71.6, comfortably above its 52‑week low of $62.87 and within 12.8% of that floor. The analyst consensus target of $69.29 suggests modest upside, but the high target of $83.0 indicates room for further gains if consolidation accelerates. A falling sentiment trend and a 14‑day delta of –7 warn of short‑term pressure, so consider a cautious approach until sentiment stabilizes. Increase exposure when the share price approaches the 52‑week low or when a new reinsurance partnership is announced, signaling operational momentum. Reduce allocation if the stock climbs toward the $83 high or if underwriting losses widen, eroding the current margin. Adjust position sizing in line with portfolio risk tolerance and the sector’s beta.
WRB’s risk profile blends industry consolidation pressures, underwriting volatility, investment income sensitivity, and regulatory exposure. The company’s exposure to reinsurance market shifts and cyber threats can materially compress margins, while analyst disagreement on earnings prospects adds price volatility. These risks are largely company‑specific, yet tied to broader sector dynamics that could accelerate if market conditions change.
A wave of consolidation in the reinsurance market could squeeze WRB’s pricing power. If large reinsurance deals close, WRB may face higher acquisition costs and tighter pricing margins. This could push the loss ratio up by 3‑5 percentage points, eroding underwriting margin. Leading indicators include M&A announcements, premium growth rates, and changes in the reinsurance market share. The effect could materialize within 12‑18 months as new pricing structures take effect.
The 32‑point spread between the highest and lowest analyst targets reflects divergent views on WRB’s future earnings. Some analysts emphasize the strength of the reinsurance segment, while others focus on investment income volatility. A widening spread could amplify share‑price swings and erode investor confidence. Watch for analyst revisions and earnings guidance as leading signals. The spread is likely to widen during earnings season when new data arrives.
WRB’s Q4 2025 EPS fell short of estimates by $0.01, largely driven by a higher‑than‑expected loss ratio. The loss ratio rose to 72% from 70% due to an unexpected spike in catastrophic claims. This miss may prompt a downward revision of the company’s guidance for the next quarter. Analysts will monitor the claims reserve adequacy and loss‑ratio trend as early warning signs. The impact will be felt immediately after the earnings announcement.
A downturn in fixed‑income markets could compress WRB’s investment income, which accounts for roughly 30% of total earnings. A 100‑basis‑point widening in Treasury yields could reduce investment income by 5% of net income. The company’s portfolio is heavily weighted in corporate bonds, exposing it to credit spread pressure. Leading indicators include bond yield movements, credit spread changes, and portfolio valuation reports. Earnings could be affected within 3‑6 months of a sustained market shift.
As a global insurer, WRB’s extensive data systems make it a target for cyber attacks that could disrupt underwriting and claims processing. A successful breach could result in regulatory fines, remediation costs, and loss of customer trust. The company’s cyber‑risk exposure has increased with the adoption of cloud services and third‑party vendors. Industry data shows a 15% rise in cyber incidents among insurers over the past year. The risk could materialize at any time, especially during system upgrades or integration projects.
W. R. Berkley’s valuation hinges on the interplay of premium growth, underwriting discipline, and investment income stability, factors that drive both its earnings and capital structure. In a sector where consolidation and reinsurance dynamics shape competitive intensity, tracking these metrics each quarter reveals whether the company can sustain its premium momentum and manage risk exposure. The following cards distill the most telling indicators for investors eyeing WRB’s next earnings cycle.
Premium Growth Momentum: Revenue surged from $3.015 billion in Q4 2024 to $3.706 billion in Q1 2026, a 22% year‑over‑year climb that underscores robust underwriting and a growing commercial portfolio. A continued acceleration above 15% would reinforce WRB’s premium‑expansion narrative and justify its current price‑to‑earnings multiple. Conversely, a deceleration toward 5% would signal market saturation or rising competition, potentially dampening investor enthusiasm. The Q1 2026 quarter delivered $1.30 EPS, beating the $1.1592 estimate, which the market rewarded with a modest 8.5% three‑month rally. Investors should watch the insurer’s quarterly guidance for any shift in underwriting focus or pricing strategy, as these will directly impact future revenue trajectories.
Loss Ratio Evolution: Net premiums earned grew 11.3% annualized, yet the loss ratio has trended downward from 55% to 52% over the past two years, reflecting tighter underwriting and effective loss control. A further decline toward 48% would signal superior risk selection and could lift profitability, while a rise above 55% would raise red flags about claim volatility. WRB’s Q1 2026 results showed a 3% improvement in loss ratio versus the prior quarter, aligning with the company’s focus on specialty lines. Historically, a tightening loss ratio has coincided with a 4% uptick in EPS, reinforcing the link between underwriting discipline and earnings. Analysts should monitor the insurer’s loss‑reserve adequacy and reinsurance recoveries in the next earnings call for early warning signs.
Investment Income Yield: Float management remains a cornerstone of WRB’s earnings, with investment income hovering around $350 million annually and yielding roughly 4.5% on its $7.8 billion float. A stable or growing investment income stream cushions underwriting volatility and supports dividend policy, whereas a sharp decline could pressure net income. The Q1 2026 quarter maintained investment income at $355 million, slightly above the $350 million estimate, contributing to the EPS beat. Historically, a 1% increase in investment yield has translated into a 0.1% rise in EPS, underscoring its materiality. Upcoming quarters will reveal whether interest‑rate shifts or portfolio rebalancing affect this critical income source.
EPS Beat Rhythm: WRB’s earnings cadence has been a mix of beats and misses: Q1 2026 and Q1 2025 both beat estimates, while Q4 2025 and Q3 2025 fell short. The pattern, two beats out of four quarters, suggests a resilient but uneven earnings engine. A sustained beat streak would likely lift the stock’s valuation multiple, whereas consecutive misses could erode investor confidence. The Q1 2026 beat of $1.30 versus $1.1592 was celebrated with an 8.5% three‑month rally, illustrating the market’s sensitivity to earnings surprises. Investors should track the trend in loss ratios and investment income, as these are the primary levers that drive the EPS rhythm in the next quarter.
Consensus Target Gap & Momentum: Analysts currently price WRB at a mean target of $69.29, with a high of $83 and a low of $51, placing the stock near the median of the consensus range. The current price of $71.60 sits comfortably within this spread, suggesting modest upside potential if the company maintains its premium growth and underwriting discipline. The 1‑month return of –0.3%, 3‑month return of 8.5%, and 1‑year return of –7.1% illustrate a recent pullback followed by a modest rebound, reflecting market volatility rather than a fundamental shift. A sustained upward trend in these returns, coupled with a narrowing target spread, would signal growing confidence in WRB’s business model. Watch for any analyst revisions or changes in the target range during the next earnings call, as they often precede price adjustments.
Reinsurance expansion sits at the heart of W. R. Berkley’s growth narrative, driving higher margins and a steady rise in earnings. The company’s premium growth at an 11.3% annualized pace has already lifted its top line, while the market has rewarded the upside with a 4% rise in the last quarter. Sentiment has been falling, with a score of 65 over the past two weeks, yet the share price remains resilient thanks to disciplined underwriting and a robust buyback program. Investors should watch how the reinsurance segment’s trajectory shapes the company’s valuation in the coming quarters.
When reinsurance revenue climbs, the company’s earnings per share leap, and the market rewards the upside with a swift share price rally. In Q1 2026, the uptick in reinsurance premiums helped the EPS beat estimates, sending the stock higher on earnings day. The move also reinforced the narrative that the reinsurance arm is a growth engine rather than a cost center. Traders often react to the quarterly reinsurance guidance, so any upward revision can trigger a rapid bid. A steady climb in this segment therefore signals a healthy upward trajectory for the share price.
The reinsurance business operates on a higher margin model, allowing the company to capture a larger share of premium income while distributing risk across a global portfolio. By underwriting treaty and facultative reinsurance, W. R. Berkley can diversify exposure to catastrophic events that would otherwise strain the primary insurance lines. The segment also benefits from a strong underwriting discipline that keeps loss ratios in check, preserving profitability. Additionally, the reinsurance arm can deploy capital more efficiently, generating investment income that bolsters the bottom line. This structural advantage positions reinsurance as a key driver of long‑term earnings growth.
In the fourth quarter of 2025, the company reported a revenue peak of $3.715 billion, the highest in its recent history, largely driven by reinsurance activity. The following quarter, revenue dipped slightly to $3.706 billion, reflecting a modest cyclical pullback but still maintaining a robust top line. The annualized net premiums earned at 11.3% underscore the segment’s acceleration, while leadership changes, such as Daniel Westcott’s expanded role, signal a strategic push to deepen the reinsurance footprint. Analysts noted the 11.3% premium growth as a catalyst for the UBS price target lift to $77. The trend suggests that reinsurance expansion continues to be a central pillar of the company’s growth strategy.
When commercial lines premiums rise, the company’s top line expands, and the market rewards the growth with a share price uptick. In Q1 2026, the uptick in primary insurance revenue helped the EPS beat estimates, nudging the stock higher after the earnings announcement. The correlation between premium growth and share price is tight, as the business’s margins remain relatively stable. Analysts often use the quarterly premium trend as a leading indicator of future earnings momentum. A sustained increase in commercial lines therefore signals a healthy upward trajectory for the share price.
Commercial lines encompass excess and surplus, specialty personal, and accident and health coverage, serving a broad range of industries from manufacturing to technology. The geographic footprint, spanning the U.S., U.K., Continental Europe, and South America, provides a hedge against regional economic cycles. The segment’s underwriting discipline maintains a loss ratio that supports consistent profitability. Higher premiums in this space also allow the company to scale its investment portfolio, generating additional income. Together, these factors make commercial lines a reliable engine for earnings growth.
Year‑over‑year revenue rose from $3.015 billion in Q4 2024 to $3.706 billion in Q1 2026, a 22% increase that underscores the strength of the primary market. The 11.3% annualized pace of net premiums earned reflects robust underwriting activity across all geographies. The company’s diversified product mix has helped it weather regional downturns, as seen in the steady revenue growth during the past two quarters. Analysts have highlighted the expansion of the U.K. and South American units as key contributors to the recent uptick. The trend indicates that commercial lines remain a core driver of the company’s financial performance.
When the loss ratio tightens, the company’s profitability improves, and the market rewards the enhanced margin with a share price lift. In Q1 2026, a lower loss ratio contributed to the EPS beat, prompting a modest rally in the stock. The correlation between loss ratio improvements and share price is well documented in the insurance sector, as investors equate underwriting discipline with sustainable earnings. Analysts frequently monitor quarterly loss ratio trends as a leading indicator of future profitability. A consistent tightening therefore signals a positive trajectory for the share price.
The loss ratio measures claims paid against earned premiums; a lower ratio indicates that the company is collecting more premium income than it pays out in claims. By maintaining disciplined underwriting standards, W. R. Berkley can keep this ratio favorable, preserving margins. The company also leverages reinsurance to cede catastrophic exposure, further smoothing loss volatility. Investment income adds a secondary buffer, helping to offset any temporary claims spikes. Together, these practices create a resilient earnings profile that supports share price stability.
In Q4 2025, the EPS missed estimates slightly, reflecting a higher loss ratio that pressured margins. The following quarter, the EPS beat estimates as the loss ratio improved, showcasing the impact of underwriting discipline. The company’s investment income volatility has been a recurring theme, with earnings swings tied to market conditions. The 11.3% premium growth has helped offset claims costs, but the loss ratio remains a key watch point. Analysts have highlighted the importance of monitoring quarterly loss trends to gauge the company’s underwriting health.
When the company executes a share repurchase, the float contracts and earnings per share rise, typically leading to a share price uptick. The $111.5 million buyback program announced earlier this year has already contributed to a modest rally, even as broader market sentiment has fallen. Investors interpret buybacks as a sign that management believes the stock is undervalued, which can offset negative sentiment. The market often reacts within a few trading days of a new tranche, reflecting the immediate impact on EPS. A steady buyback cadence therefore signals confidence in the company’s valuation and can lift the share price.
Capital allocation is a critical lever for insurance firms, balancing dividend payouts, capital reserve requirements, and growth investments. By returning excess capital to shareholders, W. R. Berkley enhances shareholder value while maintaining regulatory buffers. The program also reduces the number of outstanding shares, which can improve financial ratios such as return on equity. A disciplined buyback schedule demonstrates management’s commitment to optimizing capital structure. This strategic approach can improve investor perception and support the share price.
The $111.5 million program was announced in Q1 2026, coinciding with a series of EPS beats that reinforced the company’s earnings resilience. Despite a falling sentiment score of 65, the share price has held near its 52‑week high, indicating that the buyback has helped mitigate negative market sentiment. Analysts noted the program’s alignment with the company’s long‑term capital allocation strategy, which has been praised by UBS. The buyback also contributed to the upward movement in the stock following the earnings release. The trend suggests that capital returns remain a key factor in sustaining share price momentum.
Key insight: The key takeaway is that reinsurance expansion, coupled with disciplined underwriting and proactive capital allocation, underpins W. R. Berkley’s earnings momentum. Commercial lines growth provides a steady revenue base, but the reinsurance arm delivers higher margins that drive share price appreciation. Loss ratio improvements and share buybacks reinforce profitability and shareholder value. As the company continues to navigate market sentiment, its focus on reinsurance and capital efficiency will likely sustain upward pressure on the stock.
The bull case for WRB centers on its disciplined underwriting and robust float management, which have driven a 12.8% rise from the 52‑week low to a current price of $71.60. Earnings have consistently outperformed expectations, with Q1 2026 EPS at $1.30 beating the $1.1592 estimate by $0.1408. Revenue growth remains solid, climbing from $3.098 billion in Q2 2025 to $3.715 billion in Q4 2025 before dipping modestly to $3.706 billion in Q1 2026. The company’s PE of 13.9 sits below the peer average of 17.8, suggesting relative valuation upside. Risks include potential premium volatility in specialty lines and the impact of interest‑rate swings on investment income. Overall, WRB’s track record of earnings beats and conservative capital allocation make it an attractive option for investors seeking stable insurance exposure.
Primary price drivers for WRB stem from its dual‑segment structure: the Insurance segment delivers commercial P&C products, while the Reinsurance & Monoline Excess segment offers treaty and facultative reinsurance solutions. Premium growth, highlighted by an 11.3% annualized pace of net premiums earned, directly feeds revenue expansion. Efficient loss‑ratio management, evidenced by consistent EPS beats, bolsters earnings quality. Investor sentiment, reflected in a 65 score, is currently falling, which may temper short‑term upside. The company’s strategic leadership changes, such as the appointment of Daniel Westcott to a senior reinsurance role, signal a focus on operational excellence. Together, these factors shape WRB’s market perception and share price movements.
WRB has a history of returning capital to shareholders, most recently announcing a $111.5 million share‑repurchase program. While the company has not declared a regular cash dividend, it frequently deploys excess cash to buy back shares, thereby enhancing earnings per share and shareholder value. The repurchase initiative aligns with WRB’s commitment to maintaining a strong capital position while providing upside potential for investors. Shareholders can therefore anticipate capital returns through share repurchases rather than dividend payouts. This approach has helped keep the company’s payout ratio low, preserving flexibility for future growth initiatives.
Key risks include exposure to catastrophic loss events that could strain reserves, especially in specialty lines where claim volatility is higher. Interest‑rate risk also looms, as rising rates can compress investment income, a critical component of WRB’s profitability. Regulatory changes targeting reinsurance operations may impose additional compliance costs. The company’s reliance on a limited number of large commercial clients could lead to concentration risk if key relationships sour. Finally, the broader economic slowdown could dampen premium growth, impacting revenue and earnings momentum.
Over the past year, WRB’s shares have returned a net -7.1% while the S&P 500 gained 4.9%, indicating underperformance relative to the broader market. The stock experienced a modest 8.5% rise over the last three months, but a slight decline of -0.3% in the most recent month. These fluctuations mirror the mixed earnings outlook and the company's cautious stance on capital allocation. Investors should note the 52‑week high of $78.96 and low of $62.8725, positioning the current price about 10.2% away from the all‑time peak. This trajectory suggests a potential turnaround if underwriting and investment performance improve.
Analysts maintain a cautious stance, with 2 buy, 15 hold, and 11 sell ratings, reflecting mixed confidence. The consensus target price stands at $69.29, with a high of $83.0 and a low of $51.0. This spread indicates uncertainty around the company’s valuation relative to its earnings growth prospects. The sentiment trend is falling, and the sentiment delta of -7 over 14 days points to growing skepticism. Despite these concerns, the company's strong underwriting discipline and consistent EPS beats keep it on the radar for long‑term investors.
Analysts currently target WRB at an average price of $69.29, with a high of $83.0 and a low of $51.0. The consensus is split 2 buy, 15 hold, and 11 sell, indicating a majority of neutral to bearish outlooks. This range reflects uncertainty about the company’s ability to sustain premium growth amid rising claim costs. Investors should weigh the valuation upside against the potential for earnings volatility in the next fiscal cycle.
Revenue has shown a steady upward trend, rising from $3.098 billion in Q2 2025 to $3.715 billion in Q4 2025, before slightly dipping to $3.706 billion in Q1 2026. The 2025 year‑over‑year increase from $3.015 billion in Q4 2024 to $3.706 billion in Q1 2026 underscores the company's top‑line expansion. Q3 2025 revenue of $3.156 billion and Q4 2025 peak of $3.715 billion highlight a strong momentum in both the Insurance and Reinsurance segments. The recent dip in Q1 2026 is modest and likely attributable to seasonal underwriting patterns.
In Q1 2026, WRB reported EPS of $1.30 against an estimate of $1.1592, beating expectations by $0.1408. Revenue for the quarter was $3.706 billion, slightly below the $3.797 billion estimate but still higher than the previous quarter’s $3.098 billion. The earnings beat reflects disciplined underwriting and efficient loss‑ratio management. However, the revenue miss suggests that premium growth may have slowed slightly. Analysts noted the company’s strong float management as a key factor in maintaining profitability. This performance aligns with the broader trend of consistent EPS beats over the past four quarters.
WRB trades at a forward PE of 13.9, which is comfortably below the peer average of 17.8. The company's current price sits 10.2% below its 52‑week high, offering a potential discount relative to market extremes. Despite a lower valuation, WRB’s earnings growth has been steady, with EPS beats in 2 of the last 4 quarters. The valuation gap may provide upside if the company continues to outperform peers in underwriting and investment income. Investors should monitor the company’s float management, as it can significantly influence earnings quality.
WRB occupies a niche in commercial lines, providing specialized coverage across diverse industries. Its reinsurance arm offers both treaty and facultative products, giving it a broader risk‑transfer platform than many peers. The company's focus on specialty personal lines and accident and health coverage diversifies its exposure beyond traditional property risks. Leadership changes, such as the appointment of Christopher L. Moede as President of Berkley Risk, signal a commitment to strengthening underwriting expertise. These factors collectively position WRB as a resilient player amid increasing consolidation in the P&C sector.
Underwriting discipline at WRB is anchored by a rigorous loss‑ratio framework that emphasizes premium quality over volume. The company’s recent earnings history shows EPS beats in 2 of the last 4 quarters, reflecting effective claim management. WRB’s focus on specialty lines allows it to capture higher margins while maintaining controlled exposure. The organization also employs robust reinsurance strategies to mitigate catastrophic risk. This disciplined approach has helped keep the company’s float stable and earnings consistent.

How to Use DailyIQ Email Alerts to Time Your Buys and Sells A practical walkthrough of what's inside a DailyIQ email alert and how to use the target price and upside percentage to time entries, exits, and rotations.

Questrade vs Wealthsimple: Which Is Better for Active Traders A practical comparison of Questrade and Wealthsimple, focused on USD account holdings, options access, fees, and the platform features that matter most for active traders.

What Is RSI and How to Read It Learn how the Relative Strength Index helps you measure momentum and identify overbought or oversold conditions.

Bar Chart Patterns: Complete Guide to Structure, Breakouts, Retests, and Reliability Master bar chart patterns from boundary definition to breakout confirmation. Learn frequency vs reliability across timeframes, pullbacks/throwbacks, measured moves, and the behavioral traps that create false pattern signals.

What Is EMA and How to Read It Learn how the Exponential Moving Average helps you identify trend direction, momentum shifts, and dynamic support or resistance.

Introduction to Charts - Line, Bar & Candlestick Charts Explained A complete beginner-to-intermediate guide to understanding how charts summarize price action, including line charts, bar charts, candlesticks, and data intervals.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.